Evaxion A/S
EVAX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001828253
No open-market purchases or sales by Evaxion A/S insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $4.93M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Evaxion A/S changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 9 | 6 | −3 |
| Shares | 227.0K | 143.5K | −83.5K (−36.8%) |
| Value | $442.0K | $377.0K | −$65.0K (−14.7%) |
New holders (1)
Institutions that held Evaxion A/S at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cutler Group LP | 200 | $0 | 0.00% |
Sold out (4)
Institutions that held Evaxion A/S at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Renaissance Technologies LLC | 11,600 | $22.0K |
| Citigroup Inc | 2,941 | $6.00K |
| Captrust Financial Advisors | 339 | $1.00K |
| Group One Trading, L.P. | 100 | $0 |